Adrian N Hobden
CIK 1191076 · View on SEC EDGAR ↗
First SEC filing: June 8, 2009 · Latest: June 8, 2009
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2009 | MYGN | S | 40,000 | $34.01 | $1,360,400 | 195,726 Direct | -16.97% | Disposed | -90.5% (price as of 2026-08-20) |
| Feb. 5, 2009 | MYGN | S | 24,000 | $83.60 | $2,006,400 | 88,992 Direct | -21.24% | Disposed | -92.3% (price as of 2026-08-20) |
| Dec. 11, 2008 | MYGN | S | 20,000 | $60.60 | $1,212,000 | 88,992 Direct | -18.35% | Disposed | -89.3% (price as of 2026-08-20) |
| Sept. 25, 2008 | MYGN | S | 15,000 | $68.54 | $1,028,100 | 67,924 Direct | -18.09% | Disposed | -90.6% (price as of 2026-08-20) |
| Sept. 19, 2008 | MYGN | S | 992 | $66.00 | $65,472 | 72,924 Direct | -1.34% | Disposed | -90.2% (price as of 2026-08-20) |
| Sept. 17, 2008 | MYGN | S | 500 | $66.49 | $33,245 | 62,924 Direct | -0.79% | Disposed | -90.3% (price as of 2026-08-20) |
| Aug. 25, 2008 | MYGN | S | 27,464 | $65.03 | $1,785,984 | 62,924 Direct | -30.38% | Disposed | -90.1% (price as of 2026-08-20) |
| Sept. 25, 2007 | MYGN | S 10b5-1 | 20,000 | $50.00 | $1,000,000 | 47,236 Direct | -29.75% | Disposed | -87.1% (price as of 2026-08-20) |
| May 23, 2007 | MYGN | S 10b5-1 | 10,000 | $40.00 | $400,000 | 46,785 Direct | -17.61% | Disposed | -83.9% (price as of 2026-08-20) |
| Jan. 3, 2007 | MYGN | S 10b5-1 | 5,000 | $32.00 | $160,000 | 46,785 Direct | -9.66% | Disposed | -79.8% (price as of 2026-08-20) |
| April 27, 2006 | MYGN | S 10b5-1 | 5,000 | $26.01 | $130,050 | 45,645 Direct | -9.87% | Disposed | -75.2% (price as of 2026-08-20) |
| Jan. 13, 2005 | MYGN | S 10b5-1 | 2,024 | $25.00 | $50,600 | 44,172 Direct | -4.38% | Disposed | -74.2% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 8, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (7,980) | $12.53 | April 20, 2010 | 7,980 | Disposed |
| June 8, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (29,178) | $10.28 | Sept. 14, 2015 | 29,178 | Disposed |
| May 27, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (40,000) | $2.39 | June 17, 2009 | 40,000 | Disposed |
| May 8, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (5,240) | $6.27 | Sept. 9, 2013 | 5,240 | Disposed |
| May 8, 2009 | MYGN | Incentive Stock Option (right to buy) | Common Stock (12,502) | $5.37 | Feb. 13, 2013 | 12,502 | Disposed |
| Feb. 5, 2009 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (24,000) | $4.78 | June 17, 2009 | 24,000 | Disposed |
| Dec. 11, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (20,000) | $4.78 | June 17, 2009 | 20,000 | Disposed |
| Sept. 29, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (21,068) | $5.12 | Oct. 21, 2008 | 21,068 | Disposed |
| Sept. 23, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (10,000) | $5.12 | Oct. 21, 2008 | 10,000 | Disposed |
| Sept. 19, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (992) | $5.12 | Oct. 21, 2008 | 992 | Disposed |
| Sept. 18, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (10,000) | $5.12 | Oct. 21, 2008 | 10,000 | Disposed |
| Sept. 17, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (500) | $5.12 | Oct. 21, 2008 | 500 | Disposed |
| Sept. 10, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (45,000) | $64.88 | Sept. 10, 2018 | 45,000 | Acquired |
| Aug. 25, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (27,464) | $5.12 | Oct. 21, 2008 | 27,464 | Disposed |
| March 10, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (10,000) | $5.12 | Oct. 21, 2008 | 10,000 | Disposed |
| Feb. 28, 2008 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (52,338) | $37.56 | Feb. 28, 2018 | 52,338 | Acquired |
| Feb. 28, 2008 | MYGN | Incentive Stock Option (right to buy) | Common Stock (2,662) | $37.56 | Feb. 28, 2018 | 2,662 | Acquired |
| Nov. 30, 2007 | MYGN | Incentive Stock Option (right to buy) | Common Stock (5,000) | $5.12 | Oct. 21, 2008 | 5,000 | Disposed |
| Sept. 26, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (45,000) | $51.08 | Sept. 26, 2017 | 45,000 | Acquired |
| Sept. 25, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (20,000) | $5.12 | Oct. 21, 2008 | 20,000 | Disposed |
| May 23, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (10,000) | $5.12 | Oct. 21, 2008 | 10,000 | Disposed |
| Feb. 21, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (31,096) | $34.43 | Feb. 21, 2017 | 31,096 | Acquired |
| Feb. 21, 2007 | MYGN | Incentive Stock Option (right to buy) | Common Stock (2,904) | $34.43 | Feb. 21, 2017 | 2,904 | Acquired |
| Jan. 3, 2007 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (5,000) | $5.12 | Oct. 21, 2008 | 5,000 | Disposed |
| Sept. 6, 2006 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (32,000) | $25.57 | Sept. 6, 2016 | 32,000 | Acquired |
| April 27, 2006 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (5,000) | $5.12 | Oct. 21, 2008 | 5,000 | Disposed |
| Feb. 16, 2006 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (27,902) | $24.40 | Feb. 16, 2016 | 27,902 | Acquired |
| Feb. 16, 2006 | MYGN | Incentive Stock Option (right to buy) | Common Stock (4,098) | $24.40 | Feb. 16, 2016 | 4,098 | Acquired |
| Sept. 14, 2005 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (20,548) | $20.56 | Sept. 14, 2015 | 20,548 | Acquired |
| Sept. 14, 2005 | MYGN | Incentive Stock Option (right to buy) | Common Stock (19,452) | $20.56 | Sept. 14, 2015 | 19,452 | Acquired |
| Feb. 17, 2005 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (40,480) | $22.12 | Feb. 17, 2015 | 40,480 | Acquired |
| Feb. 17, 2005 | MYGN | Incentive Stock Option (right to buy) | Common Stock (4,520) | $22.12 | Feb. 17, 2015 | 4,520 | Acquired |
| Jan. 13, 2005 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (2,024) | $5.12 | Oct. 21, 2008 | 2,024 | Disposed |
| Sept. 8, 2004 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (40,000) | $16.64 | Sept. 8, 2014 | 40,000 | Acquired |
| Aug. 5, 2004 | MYGN | Incentive Stock Option (right to buy) | Common Stock (3,000) | $5.12 | Oct. 21, 2008 | 3,000 | Disposed |
| Feb. 19, 2004 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (24,108) | $16.97 | Feb. 19, 2014 | 24,108 | Acquired |
| Feb. 19, 2004 | MYGN | Incentive Stock Option (right to buy) | Common Stock (5,892) | $16.97 | Feb. 19, 2014 | 5,892 | Acquired |
| Sept. 9, 2003 | MYGN | Non-Qualified Stock Option (right to buy) | Common Stock (32,379) | $12.54 | Sept. 9, 2013 | 32,379 | Acquired |
| Sept. 9, 2003 | MYGN | Incentive Stock Option (right to buy) | Common Stock (2,621) | $12.54 | Sept. 9, 2013 | 2,621 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MYGN
Ph.D. President, Myriad Pharmaceuticals, Inc.| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2007 | $465,478 | $300,761 | — | $378,292 | — | — | $9,440 | $1,153,971 |
| 2002 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.